STATE STREET CORP - HEPION PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$243,433
+29.4%
313,500
-50.0%
0.00%
Q4 2022$188,162
+19.1%
627,000
+100.0%
0.00%
Q3 2022$158,000
-11.7%
313,5000.0%0.00%
Q2 2022$179,000
-60.2%
313,500
-10.1%
0.00%
Q1 2022$450,000
+22.3%
348,910
+8.1%
0.00%
Q4 2021$368,000
-25.5%
322,7160.0%0.00%
Q3 2021$494,000
-22.7%
322,7160.0%0.00%
Q2 2021$639,000322,7160.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 923,230$2,022,0000.82%
Worth Venture Partners, LLC 233,947$512,0000.40%
PERKINS CAPITAL MANAGEMENT INC 150,000$329,0000.22%
GSA CAPITAL PARTNERS LLP 89,067$195,0000.03%
PREMIER ASSET MANAGEMENT LLC 70,000$153,0000.03%
Allen Capital Group, LLC 23,685$52,0000.01%
ZEKE CAPITAL ADVISORS, LLC 50,000$110,0000.01%
Prospera Financial Services Inc 39,300$86,0000.01%
Onex Canada Asset Management Inc. 20,000$44,0000.00%
Schonfeld Strategic Advisors LLC 95,300$208,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders